| Autor: |
Duart G; Department of Biochemistry and Molecular Biology, Institut de Biotecnologia i Biomedicina, Universitat de València, Burjassot 46100, Spain., Elazar A; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel., Weinstein JY; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel., Gadea-Salom L; Department of Biochemistry and Molecular Biology, Institut de Biotecnologia i Biomedicina, Universitat de València, Burjassot 46100, Spain., Ortiz-Mateu J; Department of Biochemistry and Molecular Biology, Institut de Biotecnologia i Biomedicina, Universitat de València, Burjassot 46100, Spain., Fleishman SJ; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 76100, Israel., Mingarro I; Department of Biochemistry and Molecular Biology, Institut de Biotecnologia i Biomedicina, Universitat de València, Burjassot 46100, Spain., Martinez-Gil L; Department of Biochemistry and Molecular Biology, Institut de Biotecnologia i Biomedicina, Universitat de València, Burjassot 46100, Spain. |
| Abstrakt: |
Several methods have been developed to explore interactions among water-soluble proteins or regions of proteins. However, techniques to target transmembrane domains (TMDs) have not been examined thoroughly despite their importance. Here, we developed a computational approach to design sequences that specifically modulate protein-protein interactions in the membrane. To illustrate this method, we demonstrated that BclxL can interact with other members of the B cell lymphoma 2 (Bcl2) family through the TMD and that these interactions are required for BclxL control of cell death. Next, we designed sequences that specifically recognize and sequester the TMD of BclxL. Hence, we were able to prevent BclxL intramembrane interactions and cancel its antiapoptotic effect. These results advance our understanding of protein-protein interactions in membranes and provide a means to modulate them. Moreover, the success of our approach may trigger the development of a generation of inhibitors targeting interactions between TMDs. |
